Dec 3, 2018 09:25AM
Nov 9, 2018 03:43PM
Nov 9, 2018 03:41PM
Nov 9, 2018 03:41PM
Oct 31, 2018 09:27AM
Oct 30, 2018 05:32PM
Oct 22, 2018 06:13AM TESARO (TSRO) Reports Updated Phase 1 GARNET Data of TSR-042 (anti-PD-1 antibody) in Patients with Recurrent or Advanced MSI-H
Oct 20, 2018 01:30AM
Oct 20, 2018 01:30AM
Sep 17, 2018 07:52AM
Sep 5, 2018 09:18AM
Sep 4, 2018 06:42PM
Sep 4, 2018 04:15PM
Sep 4, 2018 04:15PM TESARO Announces Expansion to Second Stage of JASPER Trial of ZEJULA® in Combination With TSR-042 in Non-Small Cell Lung Cancer
Sep 4, 2018 04:15PM
Aug 2, 2018 04:05PM
Aug 2, 2018 04:05PM
Jun 28, 2018 04:06PM
Jun 28, 2018 04:05PM
Jun 28, 2018 04:05PM
Jun 20, 2018 09:19AM Pre-Open Movers 06/20: (CLBS) (CLPS) (WGO) Higher; (LZB) (ORCL) (SBUX) Lower (more...)
Jun 5, 2018 05:53AM
Jun 4, 2018 06:00PM
Jun 4, 2018 06:00PM
May 4, 2018 09:09AM
May 3, 2018 04:05PM
May 3, 2018 04:05PM
Apr 24, 2018 07:05AM TESARO (TSRO) Says Quadra Trial of ZEJULA Achieved Primary Endpoint
Apr 24, 2018 07:05AM
Apr 24, 2018 07:00AM
Apr 24, 2018 07:00AM
Apr 16, 2018 09:01AM
Apr 16, 2018 09:00AM
Apr 16, 2018 09:00AM
Mar 27, 2018 09:01AM Pre-Open Movers 03/27: (ATRS) (PETX) (RHT) Higher; (LFIN) (GERN) (OSTK) Lower (more...)
Feb 28, 2018 09:19AM
Feb 27, 2018 06:04PM
Feb 27, 2018 04:05PM
Feb 27, 2018 04:05PM
Jan 16, 2018 06:39AM
Jan 12, 2018 05:30PM
Jan 12, 2018 05:30PM TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
Jan 2, 2018 09:06AM
Jan 2, 2018 04:57AM
Nov 28, 2017 08:07AM
Nov 28, 2017 08:00AM
Nov 20, 2017 09:31AM
Nov 20, 2017 07:02AM
Nov 20, 2017 07:00AM TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer
Nov 15, 2017 09:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All